Acute life-threatening cardiovascular toxicity with umbilical cord blood infusion: The role of dextran

American Journal of Hematology

Volumn 85, Issue 9, 2010, Pages 722-724

  Ma, Robert W ^a   Kwan, John M ^a   Ma, David D ^a   Fay, Keith C ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; PLASMA SUBSTITUTE;

ADULT; AGED; ALLOTRANSPLANTATION; CHEMICALLY INDUCED; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEART MUSCLE ISCHEMIA; HEMATOLOGIC NEOPLASMS; HUMAN; MALE; MIDDLE AGED;

ADULT; AGED; CORD BLOOD STEM CELL TRANSPLANTATION; DEXTRANS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLASMA SUBSTITUTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 77956477018     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21797     Document Type: Article

References (16)

1. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-10122.
2. Miller JP. A centralised Cord Blood Registry to Facilitate Allogenic, Unrelated Donor Umbilical Cord Blood Transplantation, BB-IND #7555 Safety Report; NMDP Recipient Identification #: 680-017-4, NMDP Recipient Identification #: 681-495-1. National Marrow Donor Program, Minneapolis, MN; 2009.
3. Petropoulou AD, Bellochine R, Norol F, et al. Coronary artery spasm after infusion of cryopreserved cord blood cells. Bone Marrow transplantation 2007;40:397-398. (Pubitemid 47202428)
4. Hahn T, Bunworasate U, George MC, et al. Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment. Bone marrow transplantation 2003;32:145-150.
5. Konuma T, Ooi J, Takahashi S, et al. Cardiovascular toxicity of cryopreserved cord blood cell infusion. Bone marrow transplantation 2008;41:861-865.
6. Higman MA, Port JD, Beauchamp NJ Jr, et al. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone marrow transplantation 2000;26:797-800.
7. Imai C, Kakihara T, Iwabuchi H, et al. Glomerular vasculopathy after unrelated cord blood transplantation. Pediatric nephrology (Berlin, Germany) 2003;18:399-402.
8. Lin S, Chen H, Chang J, et al. Acute renal failure induced by dextran 40-A case report. Acta Nephrologica 2000;14:115-117.
9. Leisch F. Coronary artery spasm with anaphylactoid shock due to low-molecular dextran. Dtsch Med Wochenschr 1989;114:1027-1029.
10. Klugmann S, Salvi A, Valente M, et al. Coronary artery spasm after administration of dextran 40: Implications concerning percutaneous transluminal coronary angioplasty. Am Heart J 1986;111:1202-1204.
11. Zinderman CE, Landow L, Wise RP. Anaphylactoid reactions to dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 2004. J Vasc Surg 2006;43:1004-1009.
12. Ljungstrom KG. Pretreatment with dextran 1 makes dextran 40 therapy safer. J Vasc Surg 2006;43:1070-1072.
13. Ma DD, Johnson LA, Chan PM, et al. Factors influencing myeloid stem cell (CFU-C) survival after cryopreservation of human marrow and chronic granulocytic leukemia cells. Cryobiology 1982;19:1-9.
14. Zenhausern R, Tobler A, Leoncini L, et al. Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000;79:523-526.
15. Barron ME, Wilkes MM, Navickis RJ. A systematic review of the comparative safety of colloids. Arch Surg 2004;139:552-563.
16. Tsang RK, Mok JS, Poon YS, et al. Acute renal failure in a healthy young adult after dextran 40 infusion for external-ear reattachment surgery. Br J Plast Surg 2000;53:701-703.